- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 203/18 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof
Patent holdings for IPC class C07D 203/18
Total number of patents in this class: 28
10-year publication summary
0
|
4
|
0
|
2
|
4
|
2
|
1
|
3
|
2
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
University of East Anglia | 37 |
4 |
Duke University | 3063 |
3 |
The University of North Carolina at Chapel Hill | 2024 |
3 |
Canopy Growth Corporation | 219 |
2 |
National Institute of Biological Sciences, Beijing | 97 |
2 |
Mind Medicine Inc. | 98 |
2 |
Autobahn Therapeutics, Inc. | 43 |
2 |
Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. | 3 |
2 |
Bristol-myers Squibb Company | 4875 |
1 |
3m Innovative Properties Company | 17855 |
1 |
President and Fellows of Harvard College | 5952 |
1 |
Dong-A Pharmaceutical Co., Ltd. | 72 |
1 |
Japan Tobacco Inc. | 3559 |
1 |
Latvian Institute of Organic Synthesis | 56 |
1 |
Radikal Therapeutics Inc. | 8 |
1 |
Sun Pharmaceutical Industries Limited | 749 |
1 |
Other owners | 0 |